Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
umeclidinium 62.5 µg and vilanterol 25 µg
Theravance Biopharma Ireland Umited
COPD (Chronic Obstructive Pulmonary Disease)
1 trial -
0.9% NaCl physiological saline
Hospital Authority, Hong Kong
Acute Respiratory Tract Infections
1 trial -
A single dose of liposomal bupivacaine is administered at the conclusion of surgery without adjunctive analgesics, followed by a supplemental dose 72 hours postoperatively.
The First People's Hospital of Lianyungang
Anal Fistula
1 trial -
ART initiation at time of HIV diagnosis
BRIGHT MINDS BIOSCIENCES INC.
HIV Infection
1 trial -
Abciximab local infusion
Atrium Therapeutics
Acute Anterior Myocardial Infarction
1 trial -
Accurate Prediction Artificial Intelligence Models
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Albuterol
The First People's Hospital of Lianyungang
Chronic Obstructive Pulmonary Disease
1 trial -
Albuterol eMDPI DS
Teva Pharma GmbH
Pulmonary Disease, Chronic Obstructive
1 trial -
Anti-infective therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bronchiectasis Adult
1 trial -
Antibiotic selection based on the antibiotic susceptibility testing
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastritis
1 trial -
Apolipoprotein (ApoE) detection
Grace Therapeutics
Senile Plaques
1 trial -
Aspirin
Cardiff Oncology
Platelet Dysfunction Due to Aspirin
1 trial -
Azvudine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
SARS-CoV-2 Infection
1 trial -
Benazepril
Sun Yat-sen University
Renal Function Disorder
1 trial -
Bivalirudin
The First People's Hospital of Lianyungang
ST-segment Elevation Myocardial Infarction (STEMI)
1 trial -
Blood ponction
MAIA Biotechnology
Alzheimer Blood Biomarkers
1 trial -
Botulinum Toxin Type A Injection [Botox]
The First People's Hospital of Lianyungang
Rosacea
1 trial -
Buyang Huanwu Decoction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Glaucoma
1 trial -
CT three-dimensional reconstruction
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Rectal Cancer
1 trial -
Carbon Nanoparticle Suspension Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
Cardiopulmonary Exercise Testing
Esperion Therapeutics
Intrauterine Growth Restriction
1 trial -
Cefazolin with Daptomycin
Hospital Authority, Hong Kong
Periprosthetic Joint Infection
1 trial -
Compound Norethisterone Enanthate Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Contraception Behavior
1 trial -
Cow's milk
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Respiratory Infection
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources